Supreme Court of the United States
Skip Navigation LinksHome > Search Results



Docket for 21-202
Print  Notify Me  
Search documents in this case:
No. 21-202
 
Title: Mylan Laboratories Ltd., Petitioner
v.
Janssen Pharmaceutica, N.V., et al.
Docketed: August 12, 2021
Lower Ct: United States Court of Appeals for the Federal Circuit
   Case Numbers: (2021-1071)
   Decision Date: March 12, 2021
 
Proceedings and Orders
Aug 09 2021 Petition for a writ of certiorari filed. (Response due September 13, 2021)
Petition Appendix Certificate of Word Count Proof of Service
Aug 18 2021 Motion to extend the time to file a response from September 13, 2021 to October 12, 2021, submitted to The Clerk.
Main Document
Aug 19 2021 Motion to extend the time to file a response is granted and the time is extended to and including October 12, 2021, for all respondents.
Aug 25 2021 Brief amicus curiae of Jeremy C. Doerre in support of neither party filed.
Main Document Certificate of Word Count Proof of Service
Sep 13 2021 Brief amicus curiae of Association for Accessible Medicines filed.
Main Document Certificate of Word Count Proof of Service
Sep 13 2021 Brief amicus curiae of Intel Corporation filed.
Main Document Certificate of Word Count Proof of Service
Sep 30 2021 Motion to extend the time to file a response from October 12, 2021 to November 2, 2021, submitted to The Clerk.
Main Document
Oct 01 2021 Motion to extend the time to file a response is granted and the time is further extended to and including November 2, 2021, for all respondents.
Nov 02 2021 Brief of Federal Respondent in opposition filed.
Main Document Proof of Service
Nov 02 2021 Brief of respondent Janssen Pharmaceutica NV in opposition filed.
Main Document Proof of Service Certificate of Word Count
Nov 16 2021 DISTRIBUTED for Conference of 12/3/2021.
Nov 16 2021 Reply of petitioner Mylan Laboratories Ltd. filed. (Distributed)
Main Document Certificate of Word Count Proof of Service
Nov 23 2021 Rescheduled.
Dec 29 2021 DISTRIBUTED for Conference of 1/14/2022.
Jan 18 2022 Petition DENIED. Justice Alito took no part in the consideration or decision of this petition.
Attorneys
Attorneys for Petitioners
Robert Thomas Smith
Counsel of Record
Katten Muchin Rosenman LLP
2900 K Street NW
Suite 200
Washington, DC 20007
robert.smith1@kattenlaw.com
Ph: 202-625-3616
Party name: Mylan Laboratories Ltd.


Attorneys for Respondents
Elizabeth B. Prelogar
Counsel of Record
Solicitor General
United States Department of Justice
950 Pennsylvania Avenue, NW
Washington, DC 20530-0001
SUPREMECTBRIEFS@USDOJ.GOV
Ph: 202-514-2217
Party name: Andrew Hirshfeld


Pratik Arvind Shah
Counsel of Record
Akin Gump Strauss Hauer & Feld, LLP
2001 K Street N.W.
Washington, DC 20006
pshah@akingump.com
Ph: 202-887-4210
Party name: Janssen Pharmaceutica NV


Other Attorneys
Jeremy Cooper Doerre
Counsel of Record
Tillman Wright, PLLC
3440 Toringdon Way, Suite 310
Charlotte, NC 28277
jdoerre@ti-law.com
Ph: 7042484883
Party name: Jeremy C. Doerre


Matthew S. Hellman
Counsel of Record
Jenner & Block LLP
1099 New York Ave., NW
Suite 900
Washington, DC 20001
mhellman@jenner.com
Ph: 202-639-6000
Party name: Association for Accessible Medicines


Donald B. Verrilli Jr.
Counsel of Record
Munger, Tolles & Olson LLP
601 Massachusetts Avenue, NW
Suite 500E
Washington, DC 20001-5369
donald.verrilli@mto.com
Ph: 202-220-1101
Party name: Intel Corporation

 

Opinions
Filing & Rules
Oral Arguments
Case Documents
News Media
About
Visit
Contact Us | Site Map | Help | Fellows Program | Jobs | Links | Website Policies and Notices | Privacy Policy | USA.GOV
SUPREME COURT OF THE UNITED STATES 1 First Street, NE Washington, DC 20543